
<!doctype html><html lang="en"> <head><meta charset="utf-8"> 
<title>s800 inconsistencies</title> 
<style>

.gray { background-color:rgba(125, 125, 125, 0.5); } 
.orange { background-color:rgba(210, 180, 180, 0.5); } 

.match { text-decoration: underline; 
/*
  -webkit-text-decoration-color: red;  
  text-decoration-color: red; */
    -webkit-text-decoration-line: overline underline; /* Safari */
   text-decoration-line: overline underline; 
   color:yellow;
/*   font-weight:bold; */
  
  
  } 
.LINNAEUS_only { background-color: rgba(125, 125, 125, 0.5); }
.annotated { background-color:rgba(50, 180, 180, 0.5); } 
.unannotated { background-color:rgba(214, 75, 79, 0.5); } 

.match_species { text-decoration: underline; } 
/*
ul#menu li {
/*  display:inline; 
}
.horizontal { display: inline; border-left: 3px solid darkorange; padding-left: 0.3em; }
.first { border-left: none; padding-left: 0; }
*/
ul#menu li {
list-style-type: circle;
}
table { border-collapse: collapse; } 
th, td { border: 1px solid orange; padding: 4px; } 
th {  cursor: pointer; } 
th:hover { background: yellow; }

html, body, iframe { height: 100%; }

* {
  box-sizing: border-box;
}

.row {
  display: flex;
}


/* Create two equal columns that sits next to each other */
.column {
  flex: 50%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column1 {
  flex: 30%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
/* Create two equal columns that sits next to each other */
.column2 {
  flex: 70%;
  padding: 0px;
 /*height: 300px; /* Should be removed. Only for demonstration */
}
 
</style></head><body>
<h2>20980500</h2><span class="unannotated">not annotated</span> - <span class="annotated">annotated</span> - <span class="LINNAEUS_only">LINNAEUS only</span><br><hr>Differential regulation of <span class="annotated ">human papillomavirus type 8</span> by interferon regulatory factors 3 and 7. <br><br>The genus <span class="annotated ">Beta human papillomavirus (HPV) type 8</span> is associated with nonmelanoma skin cancer in <span class="LINNAEUS_only ">patients</span> with epidermodysplasia verruciformis, and evidence for its protumorigenic potential in the general population increases. To date, strategies to suppress <span class="annotated ">genus Beta HPV</span> infections are limited. Interferon regulatory factors IRF-3 and IRF-7 play key roles in the activation of the innate immune response to <span class="unannotated ">viral</span> infections. In this study, we show for the first time that both IRF-3 and IRF-7 regulate transcription of a papillomavirus, but with opposing effects. IRF-7, expressed in the suprabasal layers of <span class="annotated ">human</span> epidermis, increased <span class="annotated ">HPV8</span> late promoter activity via direct binding to <span class="unannotated ">viral</span> DNA. UV-B light-induced activation of the <span class="annotated ">HPV8</span> promoter involved IRF-7 as a downstream effector. In contrast, IRF-3, expressed in all layers of <span class="annotated ">human</span> epidermis, induced strong <span class="annotated ">HPV8</span> suppression in primary keratinocytes. IRF-3-mediated suppression prevailed over IRF-7-induced <span class="annotated ">HPV8</span> transcription. Unlike the E6 oncoprotein of the mucosal high-risk <span class="annotated ">HPV16</span>, the <span class="annotated ">HPV8</span> E6 protein did not bind to IRF-3 and only weakly antagonized its activity. Strong antiviral activity was also observed, when keratinocytes were treated with potent IRF-3 activators, poly(I:C) or RNA bearing 5' phosphates. In conclusion, we show that IRF-3 activation induces a state of cell-autonomous immunity against HPV in primary <span class="annotated ">human</span> keratinocytes. Our study suggests that local application of IRF-3-activating compounds might constitute an attractive novel therapeutic strategy against <span class="annotated ">HPV8</span>-associated diseases, particularly in epidermodysplasia verruciformis <span class="LINNAEUS_only ">patients</span>. 
<br><br><br><hr><h3>Ann file</h3><pre>T1	Species 27 54	human papillomavirus type 8<br><br>N1	Reference T1 Taxonomy:337051<br><br>T2	Species 109 147	Beta human papillomavirus (HPV) type 8<br><br>N2	Reference T2 Taxonomy:337051<br><br>T3	Species 356 370	genus Beta HPV<br><br>N3	Reference T3 Taxonomy:337051<br><br>T4	Species 709 714	human<br><br>N4	Reference T4 Taxonomy:9606<br><br>T5	Species 736 740	HPV8<br><br>N5	Reference T5 Taxonomy:337051<br><br>T6	Species 834 838	HPV8<br><br>N6	Reference T6 Taxonomy:337051<br><br>T7	Species 936 941	human<br><br>N7	Reference T7 Taxonomy:9606<br><br>T8	Species 968 972	HPV8<br><br>N8	Reference T8 Taxonomy:337051<br><br>T9	Species 1067 1071	HPV8<br><br>N9	Reference T9 Taxonomy:337051<br><br>T10	Species 1138 1143	HPV16<br><br>N10	Reference T10 Taxonomy:337041<br><br>T11	Species 1149 1153	HPV8<br><br>N11	Reference T11 Taxonomy:337051<br><br>T12	Species 1488 1493	human<br><br>N12	Reference T12 Taxonomy:9606<br><br>T13	Species 1647 1651	HPV8<br><br>N13	Reference T13 Taxonomy:337051<br><br></pre></body></html>